News & Training
Staburo news about trainings, events and moreInterview with Staburo Managing Director Dr. Hannes Buchner
Interview with Dr. Hannes Buchner, Head of Biostatistics at Staburo GmbHThis interview was conducted by Felicitas Bahr.Hello Mr. Buchner, you are ‚Head of Biostatistics’ and run the company Staburo GmbH, alongside Josef Höfler and Roland Stieger. How did you come to...
Staburo @ BVMA symposium 2018 in Munich
Staburo at the BVMA symposium 2018 in MunichStaburo took part in the BVMA symposium on 23 November 2018, at the Sheraton Arabellapark Hotel, here in Munich.The BVMA represents the interests of its German CRO members. BVMA members maintain a lively exchange of...
STABURO @ BIO-M Workshop „Medical Writing in Clinical Trials“
Staburo @ BIOM Workshop „Medical Writing in Clinical Trials“ Medical writers aim to communicate complex clinical and scientific information clearly to a variety of target audiences. One important application of medical writing is the field of clinical trials and drug...
New Employees @ Staburo
We are very happy to welcome Dr. Lena Herich and our new trainee Kim Hoang in our team. Lena joined Staburo earlier this year with her work experience and her excellent education background. She supports our clients in the areas of biostatistics & statistical...
Staburo presentation on precision medicine @ idalab
Staburo presentation on precision medicine @idalab Dr. Nicole Krämer, project leader precision medicine and biomarkers, was invited to talk about precision medicine at the idalab seminar. In the talk, she discussed how data science may identify biomarkers that help...
Meet us at the Staburo BIO-Europe 2018 booth in Copenhagen!
Staburo’s Managing Director Roland Stieger will join the BIO-Europe for the fourth time and will enjoy the good organization and networking opportunities of this partnering conference. For the first time, we will have our own booth at the bavarian pavilion. At our...
Pilot study on Effectiveness of Cannabis to Reduce Opioid Addiction
Pilot study on Effectiveness of Cannabis to Reduce Opioid Addiction We recently performed the analysis for a pilot study, investigating whether cannabis consumption may be beneficial in helping people reduce their addiction to opioids. The results were also presented...
Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study
Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study With the help of Staburo, a typeset manuscript has been published in its final form on the Dove Medical Press Ltd website....
Scientific Advice @ BfArM
Staburo supported Scientific Advice at BfArM Staburo's Managing Director Josef Höfler prepared and took part in a Scientific Advice meeting at the agency BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) in Bonn. At the BfArM, roughly 1,000 employees...
You need support in data science?
Memberships and awards

